Identification Generic Name (2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID DrugBank Accession Number DB07958 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID (DB07958) ×  Close Weight Average: 274.315  Monoisotopic: 274.131742452  Chemical Formula C 15 H 18 N 2 O 3 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Group IIE secretory phospholipase A2 Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as indolyl carboxylic acids and derivatives. These are compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an indole ring. Kingdom Organic compounds Super Class Organoheterocyclic compounds Class Indoles and derivatives Sub Class Indolyl carboxylic acids and derivatives Direct Parent Indolyl carboxylic acids and derivatives Alternative Parents Indoles  /  Substituted pyrroles  /  Benzenoids  /  Heteroaromatic compounds  /  Primary carboxylic acid amides  /  Monocarboxylic acids and derivatives  /  Carboxylic acids  /  Azacyclic compounds  /  Organopnictogen compounds  /  Organonitrogen compounds  /  Organic oxides  /  Hydrocarbon derivatives  /  Carbonyl compounds 
 
 
  show 3 more Substituents Aromatic heteropolycyclic compound  /  Azacycle  /  Benzenoid  /  Carbonyl group  /  Carboxamide group  /  Carboxylic acid  /  Carboxylic acid derivative  /  Heteroaromatic compound  /  Hydrocarbon derivative  /  Indole  /  Indolyl carboxylic acid derivative  /  Monocarboxylic acid or derivatives  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Primary carboxylic acid amide  /  Pyrrole  /  Substituted pyrrole 
 
 
  show 11 more Molecular Framework Aromatic heteropolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key OMLOGGCSARAIGZ-UHFFFAOYSA-N InChI InChI=1S/C15H18N2O3/c1-2-3-9-4-10-6-12(8-13(16)18)17-15(10)11(5-9)7-14(19)20/h4-6,17H,2-3,7-8H2,1H3,(H2,16,18)(H,19,20) IUPAC Name 2-[2-(carbamoylmethyl)-5-propyl-1H-indol-7-yl]acetic acid SMILES CCCC1=CC2=C(NC(CC(N)=O)=C2)C(CC(O)=O)=C1 References General References Not Available External Links PubChem Compound 447739 PubChem Substance 99444429 ChemSpider 394751 ZINC ZINC000002047480 PDBe Ligand IDA PDB Entries 1oxl Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.0502 mg/mL ALOGPS logP 1.77 ALOGPS logP 1.86 Chemaxon logS -3.7 ALOGPS pKa (Strongest Acidic) 4.6 Chemaxon pKa (Strongest Basic) -3.3 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 96.18 Å 2 Chemaxon Rotatable Bond Count 6 Chemaxon Refractivity 75.7 m 3 ·mol -1 Chemaxon Polarizability 29.83 Å 3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9956 Blood Brain Barrier + 0.794 Caco-2 permeable - 0.71 P-glycoprotein substrate Non-substrate 0.6317 P-glycoprotein inhibitor I Non-inhibitor 0.9549 P-glycoprotein inhibitor II Non-inhibitor 0.9549 Renal organic cation transporter Non-inhibitor 0.9185 CYP450 2C9 substrate Non-substrate 0.8382 CYP450 2D6 substrate Non-substrate 0.8106 CYP450 3A4 substrate Non-substrate 0.6779 CYP450 1A2 substrate Non-inhibitor 0.7971 CYP450 2C9 inhibitor Non-inhibitor 0.8991 CYP450 2D6 inhibitor Non-inhibitor 0.9479 CYP450 2C19 inhibitor Non-inhibitor 0.9174 CYP450 3A4 inhibitor Non-inhibitor 0.8028 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.8566 Ames test Non AMES toxic 0.8378 Carcinogenicity Non-carcinogens 0.9132 Biodegradation Not ready biodegradable 0.8269 Rat acute toxicity 2.0242 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9923 hERG inhibition (predictor II) Non-inhibitor 0.9296    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Group IIE secretory phospholipase A2 Kind Protein Organism Humans Pharmacological action Unknown General Function Phospholipase a2 activity Specific Function PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. Has a preference for arachidonic-containing phospholipids. Gene Name PLA2G2E Uniprot ID Q9NZK7 Uniprot Name Group IIE secretory phospholipase A2 Molecular Weight 15988.525 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:27 / Updated at June 12, 2020 16:52 